- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01921556
The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial (CAROL)
The Improving Care in Chronic Obstructive Lung Disease Study: CAROL Improving Processes of Care and Quality of Life of COPD Patients in Primary Care: A Cluster Randomized Trial
Background The Swiss health ministry launched a national quality program "QualiCCare" in 2011 to improve healthcare for patients with COPD.
The aim of this study is to determine whether participation in the COPD quality initiative ("QualiCCare") improves adherence to recommended clinical processes and shows impact on patients COPD care and on quality of life in patients with COPD.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The care in obstructive lung disease study (CAROL) is a cluster-randomized controlled trial with randomization on the practice level. Thirty practices will be randomly assigned to equally sized intervention group or control group.
Each General Practioner (GP) of a practice will approach consecutively and regardless the reason for the current encounter, COPD patients diagnosed by spirometric evaluation (FEV1/ FVC < 0.70), aged 45 years older, with a smoking history of = 10 pack-years (PY). GPs in the intervention group will receive "QualiCCare" education, which addresses knowledge, decision-making and behavioural aspects as well as delivery of care according to COPD quality indicators and evidence based key elements. In the control group no educational intervention will be applied and COPD patients will be treated as usual. The study period is one year.
The primary outcome measure is an aggregated score of relevant clinical processes defining elements in the care of patients with COPD: smoking cessation counseling, influenza vaccination, motivation for physical activity, appropriate pharmacotherapy, patient education and collaborative care.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8091
- Institute of General Practice, University of Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Males and females = 45yrs of age and
- Smoker or ex-smoker (with at least 10 PY) and
- Obstruction in spirometry FEV1/FVC< 0.7
Exclusion criteria:
- No obstruction in spirometry (FEV1/FVC > 0.7) or
- Patients with history of asthma or hay fever or
- Other concomitant pulmonary disease or
- Patients with malignancies of any other system and/or other severe disease with an estimated life expectancy of less than six months or
- Insufficient German language skills or
- Patients who contact the practice for emergencies only or as a substitute practice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: QualiCCare education
"QualiCCare"education is a training workshop designed to educate professionals on the guidelines but also and particularly governing professional behavior by feedback, reminders and pathways that help to change their attitudes and care behavior.
Based on behavioral and learning theory, QualiCCare intervention not only tries to increase knowledge but also internal motivation and decision making by stimuli and resources and by written instruments that guide evidence based decision support.
|
Physicians randomized into the intervention group get a "QualiCCare" training workshop designed to educate professionals on the guidelines but also and particularly governing professional behavior by feedback, reminders and pathways that help to change their attitudes and care behavior.
Based on behavioral and learning theory, QualiCCare intervention not only tries to increase knowledge but also internal motivation and decision making by stimuli and resources and by written instruments that guide evidence based decision support.
|
|
No Intervention: usual care
The practices randomized to the control group apply care as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
"Quality of care process"
Time Frame: one year
|
Difference in "quality of care process" (total increase in performed measures/fulfilled indicators) will be assessed after one year between COPD patients in the intervention and control group as reported by the patient
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: one year
|
We use the COPD Assessment Test (CAT).
The CAT provides clinicians and patients with a reliable measure of overall COPD-related health status for the assessment and long-term follow-up of individual patients.
The CAT is a validated short and simple patient-completed questionnaire that has been developed for use in routine clinical practice to measure the health status and grading the impact of COPD on patients' life.
The CAT has very similar discriminative properties to the much more complex SGRQ (St.
Georges Respiratory Questionnaire), and is available in different languages.
It compromises 8 simple questions, 8 items on a scale 0-5 with a total scoring range of 0-40.
CAT score <10 low impact, 10-20 medium impact >30 very high impact of COPD on patients life
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas J. Rosemann, Prof MD, University Hospital Zurich, Institute of General Practice
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAROL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on active comparator, QualiCCare education
-
Gaziler Physical Medicine and Rehabilitation Education...Not yet recruitingStroke | Type 2 Diabetes Mellitus (T2DM)
-
Universidad de GranadaEnrolling by invitation
-
Peking University People's HospitalPeking UniversityRecruitingRehabilitation | Pelvic Floor Muscle WeaknessChina
-
Instituto Politécnico de Setúbal. Escola Superior...Centro Hospitalar Lisboa Ocidental; Universidade de Lisboa - Faculdade Letras; Centro Hospitalar de Setúbal E.P.E... and other collaboratorsUnknown
-
University of ValladolidCompletedPain | Long COVIDSpain
-
Harbin Medical UniversityRecruitingAutism Spectrum DisorderChina
-
Kahramanmaras Sutcu Imam UniversityCompletedAdolescent Health | Health | Vaccination HesitancyTurkey (Türkiye)
-
TiumBio Co., Ltd.CompletedEndometriosisUkraine, Russian Federation, Italy, Czechia, Poland
-
Eisai Inc.CompletedAlzheimer's DiseaseUnited States
-
Stanford UniversityRecruitingTreatment Resistant Depression | Bipolar II Disorder, Most Recent Episode Major Depressive | Current Depressive EpisodeUnited States